Melatonin: Characteristics, concerns, and prospects

Journal of Biological Rhythms

Volumn 20, Issue 4, 2005, Pages 291-303

  Arendt, Josephine ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Human; Light; Melatonin; Rhythms

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; ACETYLSALICYLIC ACID; ADENOSINE A2B RECEPTOR; ALCOHOL; ALPRAZOLAM; BENSERAZIDE; BENZODIAZEPINE; CAFFEINE; CHLORPROMAZINE; DIAZEPAM; ESTRADIOL; IBUPROFEN; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MELATONIN DERIVATIVE; TESTOSTERONE;

BLINDNESS; BODY POSTURE; BODY TEMPERATURE; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG URINE LEVEL; EXERCISE; GENE; GENE EXPRESSION; HORMONE RELEASE; HUMAN; JET LAG; LIGHT EXPOSURE; MENSTRUAL CYCLE; PER1 GENE; PHOTOPERIODICITY; PRIORITY JOURNAL; REVIEW; SEASONAL VARIATION; SHIFT WORKER; SLEEP WAKING CYCLE; SUPRACHIASMATIC NUCLEUS;

BLINDNESS; BODY TEMPERATURE; CIRCADIAN RHYTHM; HUMANS; MELATONIN; SLEEP; VISION; WAKEFULNESS; WORK SCHEDULE TOLERANCE;

EID: 22544455330     PISSN: 07487304     EISSN: None     Source Type: Journal    
DOI: 10.1177/0748730405277492     Document Type: Review

References (119)

1. Archer SN, Robilliard DL, Skene DJ, Smits M, Williams A, Arendt J, and von Schantz M (2003) A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 26:413-415.
2. Arendt J (1985) Mammalian pineal rhythms. Pineal Res Rev 3:161-213.
3. Arendt J (1988) Melatonin. Clin Endocrinol (Oxf) 29:205-229.
4. Arendt J (1995) Metformin and the Mammalian Pineal Gland. London: Chapman Hall.
5. Arendt J (1999) Is melatonin a photoperiodic signal in humans? Adv Exp Med Biol 460:417-424.
6. Arendt J, Bojkowski C, Folkard S, Franey C, Marks V, Minors D, Waterhouse J, Wever RA, Wildgruber C, and Wright J (1985) Some effects of melatonin and the control of its secretion in humans. Ciba Found Symp 117:266-283.
7. Arendt J, Skene DJ, Middleton B, Lockley SW, and Deacon S (1997) Efficacy of melatonin treatment in jet lag, shift work, and blindness. J Biol Rhythms 12:604-617.
8. Bartsch C and Bartsch H (1997) [Significance of melatonin in malignant diseases]. Wien Klin Wochenschr 109:722-729.
9. Blask DE, Sauer LA, and Dauchy RT (2002) Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chcm 2:113-132.
10. Bojkowski CJ and Arendt J (1988) Annual changes in 6-sulphatoxymelatonin excretion in man. Acta Endocrinol (Copcnh) 117:470-476.
11. Bojkowski CJ and Arendt J (1990) Factors influencing urinary 6-sulphatoxymelatonin, a major melatonin metabolite, in normal human subjects. Clin Endocrinol (Oxf) 33:435-444.
12. Bojkowski CJ, Arendt J, Shih MC, and Markey SP (1987) Melatonin secretion in humans assessed by measuring its metabolite, 6-sulfatoxymelatonin. Clin Chem 33:1343-1348.
13. Brainard GC, Kavet R, and Kheifets LI (1999) The relationship between electromagnetic field and light exposures to melatonin and breast cancer risk: a review of the relevant literature. J Pineal Res 26:65-100.
14. Broadway J, Arendt J, and Folkard S (1987) Bright light phase shifts the human melatonin rhythm during the Antarctic winter. Neurosci Lett 79:185-189.
15. Brown EN, Choe Y, Shanahan TL, and Czeisler CA (1997) A mathematical model of diurnal variations in human plasma melatonin levels. Am J Physiol 272:E506-E516.
16. Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, Ford I (2005) Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev 9:41-50.
17. Buxton OM, Lee CW, L'Hermite-Baleriaux M, Turek FW, and Van Cauter E (2003) Exercise elicits phase shifts and acute alterations of melatonin that vary with circadian phase. Am J Physiol Regul Integr Comp Physiol 284:R714-R724.
18. Cajochen C, Krauchi K, and Wirz-Justice A (1997) The acute soporific action of daytime melatonin administration: effects on the EEG during wakefulness and subjective alertness. J Biol Rhythms 12:636-643.
19. Cavallo A and Dolan LM (1996) 6-Hydroxymelatonin sulfate excretion in human puberty. J Pineal Res 21:225-230.
20. Czeisler CA, Duffy JF, Shanahan TL, Brown EN, Mitchell JF, Rimmer DW, Ronda JM, Silva EJ, Allan JS, Emens JS, et al. (1999) Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 284:2177-2181.
21. Davis FC (1997) Melatonin: role in development. J Biol Rhythms 12:498-508.
22. De Leersnyder H, De Blois MC, Claustrat B, Romana S, Albrecht U, Von Kleist-Retzow JC, Delobel B, Viot G, Lyonnet S, Vekemans M, et al. (2001) Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome. J Pediatr 139:111-116.
23. de Reviers MM, Ravault JP, Tillet Y, and Pelletier J (1989) Melatonin binding sites in the sheep pars tuberalis. Neurosci Lett 100:89-93.
24. Deacon S and Arendt J (1995) Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in a dose-dependent manner in humans. Brain Res 688:77-85.
25. Deacon S and Arendt J (1996) Adapting to phase shifts: I. An experimental model for jet lag and shift work. Physiol Behav 59:665-673.
26. Duffy JF and Dijk DJ (2002) Getting through to circadian oscillators: why use constant routines? J Biol Rhythms 17:4-13.
27. Duffy JF, Dijk DJ, Hall EF, and Czeisler CA (1999) Relationship of endogenous circadian melatonin and temperature rhythms to self-reported preference for morning or evening activity in young and older people. J Investig Med 47:141-150.
28. Ebisawa T, Uchiyama M, Kajimura N, Kamei Y, Shibui K, Kim K, Kudo Y, Iwase T, Sugishita M, Jodoi T, et al. (2000) Genetic polymorphisms of human melatonin 1b receptor gene in circadian rhythm sleep disorders and controls. Neurosci Lett 280:29-32.
29. Ekman AC, Leppaluoto J, Huttunen P, Aranko K, and Vakkuri O (1993) Ethanol inhibits melatonin secretion in healthy volunteers in a dose-dependent randomized double blind cross-over study. J Clin Endocrinol Metab 77:780-783.
30. Elliott JA, Huegel GO, Youngstedt SD, and Kripke DF (2002) Circadian phase shifts to light measured from four phase markers of 6-sulphatoxymelatonin excretion. Chronobiol Int 19:968-969.
31. Erren TC and Stevens RG (2002) Light, melatonin and internal cancers-recent facts and research perspectives. Gesundheitswesen 64:278-283.
32. Filipski E, Delaunay F, King VM, Wu MW, Claustrat B, Grechez-Cassiau A, Guettier C, Hastings MH, and Francis L (2004) Effects of chronic jet lag on tumor progression in mice. Cancer Res 64:7879-7885.
33. Fu L and Lee CC (2003) The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 3:350-361.
34. Gamst A, Wolfson T, and Parry B (2004) Local polynomial regression modeling of human plasma melatonin levels. J Biol Rhythms 19:164-174.
35. Geoffriau M, Claustrat B, and Veldhuis J (1999) Estimation of frequently sampled nocturnal melatonin production in humans by deconvolution analysis: evidence for episodic or ultradian secretion. J Pineal Res 27:139-144.
36. Gibbs M, Hampton S, Morgan L, and Arendt J (2002) Adaptation of the circadian rhythm of 6-sulphatoxymelatonin to a shift schedule of seven nights followed by seven days in offshore oil installation workers. Neurosci Lett 325:91-94.
37. Gibertini M, Graham C, and Cook MR (1999) Self-report of circadian type reflects the phase of the melatonin rhythm. Biol Psychol 50:19-33.
38. Gomez Brunet A, Malpaux B, Daveau A, Taragnat C, and Chemineau P (2002) Genetic variability in melatonin secretion originates in the number of pinealocytes in sheep. J Endocrinol 172:397-404.
39. Gordijn MC, Beersma DG, Korte HJ, and van den Hoofdakker RH (1999) Effects of light exposure and sleep displacement on dim light melatonin onset. J Sleep Res 8:163-174.
40. Griefahn B, Kunemund C, Blaszkewicz M, Golka K, Mehnert P, and Degen G (2001) Experiments on the effects of a continuous 16.7 Hz magnetic field on melatonin secretion, core body temperature, and heart rates in humans. Bioelectromagnetics 22:581-588.
41. Hack LM, Lockley SW, Arendt J, and Skene DJ (2003) The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects. J Biol Rhythms 18:420-429.
42. Hartter S, Nordmark A, Rose DM, Bertilsson L, Tybring G, and Laine K (2003) Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity. Br J Clin Pharmacol 56:679-682.
43. Hartter S, Wang X, Weigmann H, Friedberg T, Arand M, Oesch F, and Hiemke C (2001) Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin. J Clin Psychopharmacol 21:167-174.
44. Hebert M, Martin SK, Lee C, and Eastman CI (2002) The effects of prior light history on the suppression of melatonin by light in humans. J Pineal Res 33:198-203.
45. Herxheimer A and Petrie KJ (2002) Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev:CD001520.
46. Hill SM, Collins A, and Kiefer TL (2000) The modulation of oestrogen receptor-alpha activity by melatonin in MCF-7 human breast cancer cells. Eur J Cancer 36(Suppl 4):117-118.
47. Illnerova H and Vanecek J (1988) Entrainment of the rat pineal rhythm in melatonin production by light. Reprod Nutr Dev 28515-526.
48. Kauppila A, Kivela A, Pakarinen A, and Vakkuri O (1987) Inverse seasonal relationship between melatonin and ovarian activity in humans in a region with a strong seasonal sonal contrast in luminosity. J Clin Endocrinol Metab 65:823-828.
49. Kennaway DJ, Lushington K, Dawson D, Lack L, van den Heuvel C, and Rogers N (1999) Urinary 6-sulfatoxymelatonin excretion and aging: new results and a critical review of the literature. J Pineal Res 27:210-220.
50. Klerman EB, Gershengorn HB, Duffy JF, and Kronauer RE (2002) Comparisons of the variability of three markers of the human circadian pacemaker. J Biol Rhythms 17:181-193.
51. Klerman EB, Zeitzer JM, Duffy JF, Khalsa SB, and Czeisler CA (2001) Absence of an increase in the duration of the circadian melatonin secretory episode in totally blind human subjects. J Clin Endocrinol Metab 86:3166-3170.
52. Kostoglou-Athanassiou I, Athanassiou P, Treacher DF, Wheeler MJ, and Forsling ML (1998) Neurohypophysial hormone and melatonin secretion over the natural and suppressed menstrual cycle in premenopausal women. Clin Endocrinol (Oxf) 49:209-216.
53. la Fleur SE, Kalsbeek A, Wortel J, van der Vliet J, and Buijs RM (2001) Role for the pineal and melatonin in glucose homeostasis: pinealectomy increases night-time glucose concentrations. J Neuroendocrinol 13:1025-1032.
54. Laughlin GA, Loucks AB, and Yen SS (1991) Marked augmentation of nocturnal melatonin secretion in amenorrheic athletes, but not in cycling athletes: unaltered by opioidergic or dopaminergic blockade. J Clin Endocrinol Metab 73:1321-1326.
55. Lerner A, Case JD, and Takahashi Y (1958) Isolation of melatonin, pineal factor that lightens melanocytes. J Am Chem Soc 80:2857-2865.
56. Lerner AB and Nordlund JJ (1978) Melatonin: clinical pharmacology. J Neural Transm Supp 1:339-347.
57. Lewy AJ, Ahmed S, Jackson JM, and Sack RL (1992) Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int 9:380-392.
58. Lewy AJ, Bauer VK, Ahmed S, Thomas KH, Cutler NL, Singer CM, Moffit MT, and Sack RL (1998) The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light. Chronobiol Int 15:71-83.
59. Lewy AJ and Sack RL (1989) The dim light melatonin onset as a marker for circadian phase position. Chronobiol Int 6:93-102.
60. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, and Markey SP (1980) Light suppresses melatonin secretion in humans. Science 210:1267-1269.
61. Lincoln GA, Andersson H, and Loudon A (2003) Clock genes in calendar cells as the basis of annual timekeeping in mammals-a unifying hypothesis. J Endocrinol 179:1-13.
62. Lincoln GA and Clarke IJ (1994) Photoperiodically-induced cycles in the secretion of prolactin in hypothalamopituitary disconnected rams: evidence for translation of the melatonin signal in the pituitary gland. J Neuroendocrinol 6:251-260.
63. Lissoni P, Bolis S, Brivio F, and Fumagalli L (2000) A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies. Anticancer Res 20:2103-2105.
64. Lissoni P, Chilelli M, Villa S, Cerizza L, and Tancini G (2003) Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res 35:12-15.
65. Liu C, Weaver DR, Jin X, Shearman LP, Pieschl RL, Gribkoff VK, and Reppert SM (1997) Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 19:91-102.
66. Lockley SW, Skene DJ, Arendt J, Tabandeh H, Bird AC, and Defrance R (1997) Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab 82:3763-3770.
67. Luboshitzky R, Wagner O, Lavi S, Herer P, and Lavie P (1997) Abnormal melatonin secretion in hypogonadal men: the effect of testosterone treatment. Clin Endocrinol (Oxf) 47:463-469.
68. Macchi MM, Bruce JA, Boulos Z, Cooper TB, Terman JS, and Terman M (2002) Sleep, chronotype and seasonality after pineal resection in humans: initial findings. Soc Res Biol Rhythms Abstr 9:157.
69. Maestroni GJ (1998) The photoperiod transducer melatonin and the immune-hematopoietic system. J Photochem Photobiol B 43:186-192.
70. Mahle CD, Goggins GD, Agarwal P, Ryan E, and Watson AJ (1997) Melatonin modulates vascular smooth muscle tone. J Biol Rhythms 12:690-696.
71. Mann K, Bauer H, Hiemke C, Roschke J, Wetzel H, and Benkert O (1996) Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretion. Eur Neuropsychopharmacol 6:163-168.
72. Masana MI and Dubocovich ML (2001) Melatonin receptor signaling: finding the path through the dark. Sci STKE 2001:PE39.
73. Messager S, Ross AW, Barrett P, and Morgan PJ (1999) Decoding photoperiodic time through Per1 and ICER gene amplitude. Proc Natl Acad Sci U S A 96:9938-9943.
74. Middleton B, Arendt J, and Stone BM (1996) Human circadian rhythms in constant dim light (8 lux) with knowledge of clock time. J Sleep Res 5:69-76.
75. Middleton B, Arendt J, and Stone BM (1997) Complex effects of melatonin on human circadian rhythms in constant dim light. J Biol Rhythms 12:467-477.
76. Migaud M, Gavet S, and Pelletier J (2002) Partial cloning and polymorphism of themelatonin1a (Mel1a) receptor gene in two breeds of goat with different reproductive seasonality. Reproduction 124:59-64.
77. Monteleone P, Forziati D, Orazzo C, and Maj M (1989) Preliminary observations on the suppression of nocturnal plasma melatonin levels by short-term administration of diazepam in humans. J Pineal Res 6:253-258.
78. Monteleone P, Tortorella A, Borriello R, Natale M, Cassandro P, and Maj M (1997) Suppression of nocturnal plasma melatonin levels by evening administration of sodium valproate in healthy humans. Biol Psychiatry 41:336-341.
79. Murphy PJ, Myers BL, and Badia P (1996) Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans. Physiol Behav 59:133-139.
80. Naidoo R (1999) Circadian rhythms in the intensive care unit, PhD thesis, University of Surrey, School of Biomedical and Molecular Sciences, Guildford, Surrey.
81. Nathan PJ, Jeyaseelan AS, Burrows GD, and Norman TR (1998) Modulation of plasma melatonin concentrations by changes in posture. J Pineal Res 24:219-223.
82. Niles L (1991) Melatonin interaction with the benzodiazepine-GABA receptor complex in the CNS. Adv Exp Med Biol 294:267-277.
83. Nowak R, McMillen IC, Redman J, and Short RV (1987) The correlation between serum and salivary melatonin concentrations and urinary 6-hydroxymelatonin sulphate excretion rates: two non-invasive techniques for monitoring human circadian rhythmicity. Clin Endocrinol (Oxf) 27:445-452.
84. Okatani Y, Morioka N, and Wakatsuki A (2000) Changes in nocturnal melatonin secretion in perimenopausal women: correlation with endogenous estrogen concentrations. J Pineal Res 28:111-118.
85. Owen J and Arendt J (1992) Melatonin suppression in human subjects by bright and dim light in Antarctica: time and season-dependent effects. Neurosci Lett 137:181-184.
86. Perreau-Lenz S, Pevet P, Buijs RM, and Kalsbeek A (2004) The biological clock: the bodyguard of temporal homeostasis. Chronobiol Int 21:1-25.
87. Poirel VJ, Boggio V, Dardente H, Pevet P, Masson-Pevet M, and Gauer F (2003) Contrary to other non-photic cues, acute melatonin injection does not induce immediate changes of clock gene mRNA expression in the rat suprachiasmatic nuclei. Neuroscience 120:745-755.
88. Rajaratnam SM and Arendt J (2001) Health in a 24-h society. Lancet 358:999-1005.
89. Rajaratnam SM, Dijk DJ, Middleton B, Stone BM, and Arendt J (2003) Melatonin phase-shifts human circadian rhythms with no evidence of changes in the duration of endogenous melatonin secretion or the 24-hour production of reproductive hormones. J Clin Endocrinol Metab 88:4303-4309.
90. Rajaratnam SM, Middleton B, Stone BM, Arendt J, and Dijk DJ (2004) Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans. J Physiol 561:339-351.
91. Reiter RJ (2003) Melatonin: clinical relevance. Best Pract Res Clin Endocrinol Metab 17:273-285.
92. Reppert SM (2000) Cellular and molecular basis of circadian timing in mammals. Semin Perinatal 24:243-246.
93. Reppert SM, Weaver DR, Cassone VM, Godson C, and Kolakowski LF Jr (1995) Melatonin receptors are for the birds: molecular analysis of two receptor subtypes differentially expressed in chick brain. Neuron 15:1003-1015.
94. Revell VL, Arendt J, Terman M, and Skene DJ (in press) Short-wavelength sensitivity of the human circadian system to phase advancing light. J Biol Rhythms.
95. Roenneberg T and Aschoff J (1990) Annual rhythm of human reproduction: I. Biology, sociology, or both? J Biol Rhythms 5:195-216.
96. Rojansky N, Benshushan A, Meirsdorf S, Lewin A, Laufer N, and Safran A (2000) Seasonal variability in fertilization and embryo quality rates in women undergoing IVF. Fertil Steril 74:476-481.
97. Ross JK, Arendt J, Horne J, and Haston W (1995) Night-shift work in Antarctica: sleep characteristics and bright light treatment. Physiol Behav 57:1169-1174.
98. Sauer LA, Dauchy RT, and Blask DE (2001) Polyunsaturated fatty acids, melatonin, and cancer prevention. Biochem Pharmacol 61:1455-1462.
99. Scheer FA, Van Montfrans GA, van Someren EJ, Mairuhu G, and Buijs RM (2004) Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 43:192-197.
100. Schernhammer ES and Schulmeister K (2004) Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? Br J Cancer 90:941-943.
101. Shilo L, Sabbah H, Hadari R, Kovatz S, Weinberg U, Dolev S, Dagan Y, and Shenkman L (2002) The effects of coffee consumption on sleep and melatonin secretion. Sleep Med 3:271-273.
102. Simonneaux V and Ribelayga C (2003) Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides and other pineal transmitters. Pharmacol Rev 55:325-395.
103. Stanberry LR, Das Gupta TK, and Beattie CW (1983) Photoperiodic control of melanoma growth in hamsters: influence of pinealectomy and melatonin. Endocrinology 113:469-475.
104. Stevens RG and Davis S (1996) The melatonin hypothesis: electric power and breast cancer. Environ Health Perspect 104(Suppl 1):135-140.
105. Stone BM, Turner C, Mills SL, and Nicholson AN (2000) Hypnotic activity of melatonin. Sleep 23:663-669.
106. Tarquini B, Perfetto F, Poli R, and Tarquini R (1994) Daytime circulating melatonin levels in smokers. Tumori 80:229-232.
107. von Gall C, Garabette ML, Kell CA, Frenzel S, Dehghani F, Schumm-Draeger PM, Weaver DR, Korf HW, Hastings MH, and Stehle JH (2002) Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin. Nat Neurosci 5:234-238.
108. Voultsios A, Kennaway DJ, and Dawson D (1997) Salivary melatonin as a circadian phase marker: validation and comparison to plasma melatonin. J Biol Rhythms 12:457-466.
109. Warman GR, Tripp H, Warman VL, and Arendt J (2003) Acute exposure to circularly polarized 50-Hz magnetic fields of 200-300 microT does not affect the pattern of melatonin secretion in young men. J Clin Endocrinol Metab 88:5668-5673.
110. Warman VL, Dijk DJ, Warman GR, Arendt J, and Skene DJ (2003) Phase advancing human circadian rhythms with short wavelength light. Neurosci Lett 342:37-40.
111. Wehr TA, Schwartz PJ, Turner EH, Feldman-Naim S, Drake CL, and Rosen thai NE (1995) Bimodal patterns of human melatonin secretion consistent with a two-oscillator model of regulation. Neurosci Lett 194:105-108.
112. Weibel L, Spiegel K, Gronfier C, Follenius M, and Brandenberger G (1997) Twenty-four-hour melatonin and core body temperature rhythms: their adaptation in night workers. Am J Physiol 272:R948-R954.
113. Williams LM and Morgan PJ (1988) Demonstration of melatonin-binding sites on the pars tuberalis of the rat. J Endocrinol 119:R1-R3.
114. Wirz-Justice A, Werth E, Renz C, Muller S, and Krauchi K (2002) No evidence for a phase delay in human circadian rhythms after a single morning melatonin administration. J Pineal Res 32:1-5.
115. Wright KP Jr and Badia P (1999) Effects of menstrual cycle phase and oral contraceptives on alertness, cognitive performance, and circadian rhythms during sleep deprivation. Behav Brain Res 103:185-194.
116. Wright KP Jr, Badia P, Myers BL, Plenzler SC, and Hakel M (1997) Caffeine and light effects on nighttime melatonin and temperature levels in sleep-deprived humans. Brain Res 747:78-84.
117. Zeitzer JM, Ayas NT, Shea SA, Brown R, and Czeisler CA (2000a) Absence of detectable melatonin and preservation of cortisol and thyrotropin rhythms in tetraplegia. J Clin Endocrinol Metab 85:2189-2196.
118. Zeitzer JM, Dijk DJ, Kronauer R, Brown E, and Czeisler C (2000b) Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol 526(Pt 3):695-702.
119. Zhu Y, Brown HN, Zhang Y, Stevens RG, and Zheng T (2005) Periods structural variation: a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers Prev 14:268-270.